Ausgabe 3/2017
2017 Adana HCC Conference in Turkey
Inhalt (19 Artikel)
Molecular Pathogenesis of Liver Cancer
Mehmet Ozturk, Tugce Batur, Umut Ekin, Aybike Erdogan, Evin İscan, Umur Keles, Ozden Oz, Cigdem Ozen
Signaling Pathways as Potential Therapeutic Targets in Hepatocarcinogenesis
Yeliz Yılmaz, Ayşim Güneş, Hande Topel, Neşe Atabey
Cancer Stem Cells in Hepatocellular Carcinoma
Tamer Yagci, Metin Cetin, Pelin Balcik Ercin
Angiogenesis, Invasion, and Metastasis Characteristics of Hepatocellular Carcinoma
Şirin Yüksel, Cemaliye Boylu Akyerli, M. Cengiz Yakıcıer
Barcelona Clinic Liver Cancer (BCLC) Staging: Does It Cover All Our Expectation
Abdullah Sonsuz
Validation of a Liver Index and Its Significance for HCC Aggressiveness
Brian I. Carr, Vito Guerra
Liver Transplantation for Hepatocellular Carcinoma: Kent Hospital Experience
Cahit Yılmaz
Liver Transplantation for Hepatocellular Carcinoma at Inonu University
Cuneyt Kayaalp, Volkan Ince, Veysel Ersan, Serdar Karakas, Aysegul Sagir Kahraman, Sezai Yilmaz
Liver Transplantation for Hepatocellular Carcinoma: “Experience of Memorial Sisli Hospital”
Koray Acarlı
HCC Locoregional Therapies: Yttrium-90 (Y-90) Selective Internal Radiation Therapy (SIRT)
İsa Burak Güney
Yttrium-90 (Y-90) Resin Microsphere Therapy for Patients with Unresectable Hepatocellular Carcinoma: a Single-Center Experience
Semra İnce, Bülent Karaman, Engin Alagoz, Nuri Karadurmuş, Hüseyin Şan, Cemal Nuri Erçin, Nuri Arslan
Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, mRECIST, and Others
Mecit Kantarci, Berhan Pirimoglu
The Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer
Ali Oğul, Berksoy Şahin, Ferit Kuşçu, Onur Taktakoğlu, Abdullah Evren Yetişir, Mahmut Büyükşimşek, Cem Mirili, Serkan Gökçay, M. Gökhan Gök, Pınar Kum
Enlighting the Shadow for Advanced Hepatocellular Carcinoma: Immunotherapy with Immune Checkpoint Inhibitors
Berksoy Sahin